We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$463M
AUM Growth
+$48.8M
Cap. Flow
+$67.4M
Cap. Flow %
14.57%
Top 10 Hldgs %
9.27%
Holding
349
New
97
Increased
39
Reduced
45
Closed
81

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$4.67M
2
CHTR icon
Charter Communications
CHTR
+$3.95M
3
G icon
Genpact
G
+$3.93M
4
PCRX icon
Pacira BioSciences
PCRX
+$3.26M
5
ALKS icon
Alkermes
ALKS
+$2.94M

Sector Composition

Rank Sector Weight
1 Healthcare 22.45%
2 Technology 18.35%
3 Consumer Discretionary 17.18%
4 Consumer Staples 10.71%
5 Financials 8.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPA icon
176
Copa Holdings
CPA
$5.54B
$1.19M 0.26%
10,500
C icon
177
Citigroup
C
$221B
$1.19M 0.26%
10,500
PFE icon
178
Pfizer
PFE
$143B
$1.18M 0.26%
42,000
TARS icon
179
Tarsus Pharmaceuticals
TARS
$2.56B
$1.18M 0.25%
16,800
ANAB icon
180
AnaptysBio
ANAB
$1.63B
$1.16M 0.25%
+21,000
New +$1.13M
BIIB icon
181
Biogen
BIIB
$29.6B
$1.15M 0.25%
+6,300
New +$1.16M
PTGX icon
182
Protagonist Therapeutics
PTGX
$8.71B
$1.11M 0.24%
10,500
-2,100
-17% -$186K
CLX icon
183
Clorox
CLX
$11.3B
$1.09M 0.24%
10,500
CCL icon
184
Carnival Corporation Ltd
CCL
$34.6B
$1.09M 0.24%
+42,000
New +$1.22M
PAX icon
185
Patria Investments
PAX
$1.72B
$1.06M 0.23%
84,000
+42,000
+100% +$591K
GLUE icon
186
Monte Rosa Therapeutics
GLUE
$1.95B
$1.04M 0.22%
+63,000
New +$1.2M
DUOL icon
187
Duolingo
DUOL
$5.62B
$1.03M 0.22%
10,500
+6,300
+150% +$777K
FOR icon
188
Forestar Group
FOR
$1.42B
$1.03M 0.22%
+42,000
New +$1.12M
MPC icon
189
Marathon Petroleum
MPC
$91.2B
$1.03M 0.22%
4,200
-2,100
-33% -$424K
INVX
190
Innovex International
INVX
$1.86B
$1.02M 0.22%
42,000
SJM icon
191
J.M. Smucker
SJM
$12.4B
$1.01M 0.22%
10,500
KNSA icon
192
Kiniksa Pharmaceuticals
KNSA
$4.85B
$1.01M 0.22%
+21,000
New +$930K
RPRX icon
193
Royalty Pharma
RPRX
$26.2B
$1.01M 0.22%
21,000
-42,000
-67% -$1.84M
MSM icon
194
MSC Industrial Direct
MSM
$7.03B
$969K 0.21%
+10,500
New +$940K
CNA icon
195
CNA Financial
CNA
$14.1B
$964K 0.21%
+21,000
New +$994K
OLED icon
196
Universal Display
OLED
$3.71B
$962K 0.21%
10,500
-6,300
-38% -$697K
DBX icon
197
Dropbox
DBX
$6.63B
$954K 0.21%
+42,000
New +$1.07M
TTD icon
198
Trade Desk
TTD
$7.89B
$953K 0.21%
+42,000
New +$1.21M
RIVN icon
199
Rivian
RIVN
$23.8B
$948K 0.21%
+63,000
New +$1.01M
KHC icon
200
Kraft Heinz
KHC
$30.1B
$945K 0.2%
42,000

Similar funds

Hussman Strategic Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Hussman Strategic Advisors held 349 positions worth $463M, up 12% from $414M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Hussman Strategic Advisors deployed $67.4M of net new capital in Q1 2026, opening 97 new positions and adding to 39 existing holdings. Its largest new stake was American Eagle Outfitters: 210,000 shares worth $3.51M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Ubiquiti, an estimated $2.85M trimmed.

  • Hussman Strategic Advisors's largest Q1 2026 buy was American Eagle Outfitters: 210,000 shares worth $3.51M.
  • Hussman Strategic Advisors added most to Corcept Therapeutics in Q1 2026, an estimated $3.53M increase.
  • Hussman Strategic Advisors's biggest Q1 2026 reduction was Ubiquiti, cutting an estimated $2.85M.
  • Hussman Strategic Advisors fully exited Qualcomm in Q1 2026, selling an estimated $4.67M.
  • Hussman Strategic Advisors's ten largest holdings make up 9.3% of its $463M portfolio in Q1 2026.
  • Hussman Strategic Advisors opened 97 new positions and closed 81 in Q1 2026.
  • Hussman Strategic Advisors's portfolio value rose 12% quarter-over-quarter to $463M.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.